Loading...
GeneDx Holdings Corp.
WGS•NASDAQ
Healthcare
Medical - Healthcare Information Services
$79.83
$-1.62(-1.99%)
GeneDx Holdings Corp. (WGS) Financial Performance & Income Statement Overview
Review GeneDx Holdings Corp.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
50.79%
↑ 50.79%
Operating Income Growth
85.82%
↑ 85.82%
Net Income Growth
70.25%
↑ 70.25%
Operating Cash Flow Growth
84.18%
↑ 84.18%
Operating Margin
-4.20%
↓ 4.20%
Gross Margin
63.93%
↑ 63.93%
Net Profit Margin
-11.68%
↓ 11.68%
ROE
-17.12%
↓ 17.12%
ROIC
-3.68%
↓ 3.68%
GeneDx Holdings Corp. (WGS) Income Statement & Financial Overview
Review GeneDx Holdings Corp.'s (WGS) income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $87.11M | $95.64M | $76.87M | $70.51M |
| Cost of Revenue | $28.64M | $29.43M | $29.05M | $31.97M |
| Gross Profit | $58.48M | $66.20M | $47.83M | $38.54M |
| Gross Profit Ratio | $0.67 | $0.69 | $0.62 | $0.55 |
| R&D Expenses | $12.58M | $11.59M | $11.66M | $10.69M |
| SG&A Expenses | $50.45M | $45.03M | $43.17M | $37.31M |
| Operating Expenses | $63.03M | $56.61M | $54.84M | $48.87M |
| Total Costs & Expenses | $91.67M | $86.05M | $84.65M | $80.84M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | -$640000.00 | -$698000.00 | $843000.00 | $894000.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $5.93M | $5.52M |
| EBITDA | -$4.55M | $8.81M | -$1.85M | -$22.95M |
| EBITDA Ratio | -$0.05 | $0.09 | -$0.02 | -$0.33 |
| Operating Income | -$4.55M | $8.81M | -$7.78M | -$10.33M |
| Operating Income Ratio | -$0.05 | $0.09 | -$0.10 | -$0.15 |
| Other Income/Expenses (Net) | -$1.53M | -$3.37M | -$579000.00 | -$19.03M |
| Income Before Tax | -$6.08M | $5.44M | -$8.36M | -$29.36M |
| Income Before Tax Ratio | -$0.07 | $0.06 | -$0.11 | -$0.42 |
| Income Tax Expense | -$447000.00 | $0.00 | -$47000.00 | -$190000.00 |
| Net Income | -$6.53M | $5.44M | -$8.31M | -$29.17M |
| Net Income Ratio | -$0.07 | $0.06 | -$0.11 | -$0.41 |
| EPS | -$0.23 | $0.20 | -$0.31 | -$1.10 |
| Diluted EPS | -$0.23 | $0.20 | -$0.31 | -$1.10 |
| Weighted Avg Shares Outstanding | $281.48M | $26.99M | $27.10M | $26.62M |
| Weighted Avg Shares Outstanding (Diluted) | $281.48M | $26.99M | $27.10M | $26.62M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan